If you haven’t had time to catch-up on all the methods papers published in the last couple of months, here’s our take on the most important covering all aspects of HTA.
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ 2012;344:d7202
Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey. BMJ 2012;344:d7501
Understanding why evidence from randomised clinical trials may not be retrieved from Medline: comparison of indexed and non-indexed records. BMJ 2012;344:d750
Kruse M, Sørensen J, Gyrd-Hansen D. Future costs in cost-effectiveness analysis: an empirical assessment. Eur J Health Econ. 2012 Feb;13(1):63-70.
Longson CM. A little learning: reflections on 10 years of NICE technology appraisals. Health Economics, Article first published online: 6 DEC 2011 | DOI: 10.1002/hec.1820
Caro JJ, Möller J, Getsios D. Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations? Value in Health, Article first published online: 3 SEP 2010 | DOI: 10.1111/j.1524-4733.2010.00775.x